MedPage Today: Preop chemotherapy misses mark in pancreatic cancer

UC research published in JAMA Oncology shows that pre-operative chemotherapy didn't improve outcomes

Catching pancreatic cancer in earlier stages improves one's chance for survival, but University of Cincinnati researchers wanted to know if administering chemo before surgery in some patients, in addition to after, would make a difference.

Traditionally, pancreatic cancer is treated with surgery first and chemotherapy second. But Davendra Sohal, MD, associate professor of medical oncology at UC and medical oncologist with UC Health, was looking for ways to improve outcomes. So in a clinical trial, he and others enrolled 102 early-stage patients and administered chemotherapy before surgery and after.

"Unfortunately, it did not lead to a cure in more patients than the usual approach, but it has taught us important lessons about how to do it and how to make improvements upon it in future trials," says Sohal, who is also a member of the UC Cancer Center.

Read more about the study, published in JAMA Oncology, in this MedPage Today article (free subscription may be required) and this WVXU, 91.7-FM story.

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.

Related Stories

2

Researchers work to uncover new information on long-term use of...

November 5, 2024

A new chapter in obesity care has emerged. In addition to recently approved medications used for weight management — the GLP-1 receptor agonists — several additional pharmacotherapies are in the works. Yet details on the impact of long-term use are still being uncovered.

Debug Query for this